| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 622 | 20.084 | 9.711 | 19.314 | 54.104 | 138.499 |
| Total Income - EUR | - | - | - | - | 622 | 20.121 | 10.964 | 23.829 | 54.104 | 143.623 |
| Total Expenses - EUR | - | - | - | - | 304 | 6.571 | 12.326 | 17.626 | 18.447 | 32.868 |
| Gross Profit/Loss - EUR | - | - | - | - | 318 | 13.551 | -1.362 | 6.203 | 35.657 | 110.755 |
| Net Profit/Loss - EUR | - | - | - | - | 299 | 12.987 | -1.691 | 5.524 | 30.700 | 107.092 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Karaounimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 1.935 | 3.850 | 7.149 | 69.415 | 82.045 |
| Current Assets | - | - | - | - | 665 | 13.635 | 16.326 | 20.773 | 32.484 | 134.696 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 3.032 | 0 |
| Receivables | - | - | - | - | 0 | 270 | 758 | 429 | 1.918 | 10.190 |
| Cash | - | - | - | - | 665 | 13.364 | 15.568 | 20.344 | 27.534 | 124.505 |
| Shareholders Funds | - | - | - | - | 341 | 13.321 | 11.335 | 16.894 | 47.543 | 154.370 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 324 | 2.249 | 8.841 | 11.101 | 54.356 | 62.370 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Karaounimed S.r.l.